Editorial: Molecular predictive pathology in gynecologic malignancies.
作者信息
Malapelle Umberto, Uccella Stefano, Cecere Sabrina Chiara, De Angelis Carmine, Giampaolino Pierluigi
机构信息
Department of Public Health, University of Naples Federico II, Naples, Italy.
Department of Obstetrics and Gynecology, University Hospital of Verona, University of Verona, Verona, Italy.
出版信息
Front Oncol. 2023 Oct 4;13:1301768. doi: 10.3389/fonc.2023.1301768. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Molecular predictive pathology in gynecologic malignancies.社论：妇科恶性肿瘤中的分子预测病理学
Front Oncol. 2023 Oct 4;13:1301768. doi: 10.3389/fonc.2023.1301768. eCollection 2023.
2
Genomic-Based Therapy of Gynecologic Malignancies.基于基因组学的妇科恶性肿瘤治疗
Acta Med Acad. 2019 Apr;48(1):84-89. doi: 10.5644/ama2006-124.245.
3
An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology.妇科肿瘤学中用于诊断癌前病变和恶性病变的免疫组织化学和分子病理学的最新进展。
Gynecol Oncol. 2018 Aug;150(2):378-386. doi: 10.1016/j.ygyno.2018.05.023. Epub 2018 May 21.
4
Editorial: Molecular pathology and computational image analyses in gynecologic malignancies.社论：妇科恶性肿瘤中的分子病理学与计算机图像分析
Front Oncol. 2022 Nov 21;12:1082220. doi: 10.3389/fonc.2022.1082220. eCollection 2022.
5
Gynecologic biopsy for molecular profiling: a review for the interventional radiologist.用于分子谱分析的妇科活检：介入放射科医生的综述
Semin Intervent Radiol. 2013 Dec;30(4):417-24. doi: 10.1055/s-0033-1359738.
6
The incidence and predictors of gynecologic malignancies among postmenopausal patients with endometrial fluid collection.绝经后子宫内膜积液患者中妇科恶性肿瘤的发病率及预测因素。
Arch Gynecol Obstet. 2019 Apr;299(4):1071-1076. doi: 10.1007/s00404-018-4997-9. Epub 2018 Dec 5.
7
The roles of pathology in targeted therapy of women with gynecologic cancers.病理学在妇科癌症女性靶向治疗中的作用。
Gynecol Oncol. 2018 Jan;148(1):213-221. doi: 10.1016/j.ygyno.2017.11.020. Epub 2017 Nov 23.
8
Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers.错配修复缺陷/高微卫星不稳定性的频率及其作为妇科癌症免疫检查点抑制剂反应的预测生物标志物的作用。
Cancer Res Treat. 2022 Oct;54(4):1200-1208. doi: 10.4143/crt.2021.828. Epub 2021 Dec 13.
9
A preliminary study on natural killer activity in patients with gynecologic malignancies.妇科恶性肿瘤患者自然杀伤活性的初步研究。
J Tongji Med Univ. 1990;10(3):159-63. doi: 10.1007/BF02986455.
10
An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group.尝试建立用于晚期或复发性上皮性卵巢癌的聚（ADP-核糖）聚合酶抑制剂的真实世界数据库：日本妇科肿瘤学组。
J Gynecol Oncol. 2023 May;34(3):e62. doi: 10.3802/jgo.2023.34.e62. Epub 2023 Apr 21.
本文引用的文献
1
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.度伐利尤单抗治疗原发性晚期或复发性子宫内膜癌。
N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27.
2
Cancer statistics, 2023.癌症统计数据，2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Novel Therapies in Gynecologic Cancer.妇科癌症的新型治疗方法。
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-17. doi: 10.1200/EDBK_351294.
4
Comparison of Secular Trends in Cervical Cancer Mortality in China and the United States: An Age-Period-Cohort Analysis.中国和美国宫颈癌死亡率的长期趋势比较：年龄-时期-队列分析
Int J Environ Res Public Health. 2016 Nov 17;13(11):1148. doi: 10.3390/ijerph13111148.
5
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.对携带BRCA突变的肿瘤中聚（ADP - 核糖）聚合酶的抑制作用。
N Engl J Med. 2009 Jul 9;361(2):123-34. doi: 10.1056/NEJMoa0900212. Epub 2009 Jun 24.
Zotero 插件